Regen Biopharma INC (RGBPP) — 10-Q Filings

All 10-Q filings from Regen Biopharma INC. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Regen BioPharma Narrows Q3 Loss to $1,000 Amidst Zero Revenue — Aug 11, 2025 Risk: high
Regen BioPharma Inc. reported no revenue for the three and nine months ended June 30, 2025, consistent with the prior year periods. The company incurred a net l
Regen BioPharma Narrows Losses Amidst Zero Revenue, Equity Raises — May 28, 2025 Risk: high
Regen BioPharma Inc. reported no revenue for the three and six months ended March 31, 2025, consistent with the prior year periods. The company incurred a net l
Regen BioPharma Files Q1 2025 10-Q — May 16, 2025 Risk: medium
Regen BioPharma Inc. filed its 10-Q for the period ending December 31, 2024. The filing covers the first quarter of their fiscal year, which began on October 1,
Regen BioPharma Files 10-Q for Q2 2024 — Aug 13, 2024 Risk: medium
Regen BioPharma Inc. filed its 10-Q for the period ending June 30, 2024. The company's fiscal year ends on September 30th. Key financial data and preferred stoc
Regen BioPharma Inc. Files 10-Q for Period Ending March 31, 2024 — Apr 24, 2024 Risk:
Regen BioPharma Inc (RGBPP) filed a Quarterly Report (10-Q) with the SEC on April 24, 2024. Regen BioPharma Inc. filed a 10-Q report for the period ending March
Regen BioPharma Inc. Files 10-Q for Period Ending December 31, 2023 — Jan 19, 2024 Risk: low
Regen BioPharma Inc (RGBPP) filed a Quarterly Report (10-Q) with the SEC on January 19, 2024. Regen BioPharma Inc. filed a 10-Q report for the period ending Dec

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX